Aurolife pharma adderall?

What is Aurolife Pharma's Adderall generic version?

Aurolife Pharma's Adderall generic version is a pharmaceutical product that is essentially equivalent to the branded version of Adderall, which is manufactured by Teva Pharmaceutical Industries [1]. Adderall is a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy [2].

What are the key differences between Aurolife Pharma's Adderall and the branded version?

According to the DrugPatentWatch.com database, Aurolife Pharma's generic version of Adderall contains the same active ingredients (amphetamine and dextroamphetamine) in a similar formulation as the branded version [1]. However, the inactive ingredients and the manufacturer's production process may differ.

How does Aurolife Pharma's Adderall compare to other generic versions?

Aurolife Pharma's Adderall is one of several generic versions of Adderall available in the market. Other generic manufacturers, such as Mylan, Sandoz, and Mallinckrodt, also offer their own versions of the medication. While each generic version must meet the same quality and efficacy standards as the branded product, there may be subtle differences in the formulation or production process.

Can patients switch to Aurolife Pharma's Adderall if they are currently taking the branded version?

Switching to Aurolife Pharma's Adderall should be discussed with a healthcare professional, as they can assess whether the generic version is suitable for an individual patient. Patients should also be aware that the inactive ingredients and manufacturer's production process may differ, which could potentially cause side effects or interact with other medications [3].

When does the patent for Adderall expire?

The patent for Adderall (amphetamine and dextroamphetamine) expired in 1992, allowing generic versions of the medication to enter the market. However, patent extensions and exclusivity arrangements have been granted to the branded manufacturer, Teva Pharmaceutical Industries, which has delayed the entry of generic versions until 2015 [4].

References

[1] DrugPatentWatch.com – Adderall (amphetamine and dextroamphetamine) generic version
[2] MedlinePlus – Adderall (amphetamine and dextroamphetamine)
[3] Mayo Clinic – Adderall: Side effects
[4] US Patent and Trademark Office – Patent expiration date for Adderall

Sources:
1. https://drugpatentwatch.com/drug/1657/adderall-amphetamine-dextroamphetamine
2. https://medlineplus.gov/druginfo/meds/a601043.html
3. https://www.mayoclinic.org/drugs-supplements/adderall-oral-route/side-effects/drg-20064423
4. https://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=Y&QUNIT=1&OP=Beg&QS=COM&B1=1&COST=&s2=Yh2p4w2Jk4NQm4N